Your browser doesn't support javascript.
loading
Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.
Kim, Bu-Yeo; Jeong, SangKyun; Lee, Seo-Young; Lee, So Min; Gweon, Eun Jeong; Ahn, Hyunjun; Kim, Janghwan; Chung, Sun-Ku.
Afiliação
  • Kim BY; Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Yuseong-gu, Daejeon, South Korea.
  • Jeong S; Medical Research Division, Korea Institute of Oriental Medicine, Yuseong-gu, Daejeon, South Korea.
  • Lee SY; Medical Research Division, Korea Institute of Oriental Medicine, Yuseong-gu, Daejeon, South Korea.
  • Lee SM; Medical Research Division, Korea Institute of Oriental Medicine, Yuseong-gu, Daejeon, South Korea.
  • Gweon EJ; Medical Research Division, Korea Institute of Oriental Medicine, Yuseong-gu, Daejeon, South Korea.
  • Ahn H; Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon, South Korea.
  • Kim J; Korea University of Science and Technology, Yuseong-gu, Daejeon, South Korea.
  • Chung SK; Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon, South Korea.
Exp Mol Med ; 48(6): e237, 2016 06 03.
Article em En | MEDLINE | ID: mdl-27256111

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Receptores de Ativinas Tipo I / Células-Tronco Pluripotentes Induzidas / Edição de Genes / Miosite Ossificante Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Receptores de Ativinas Tipo I / Células-Tronco Pluripotentes Induzidas / Edição de Genes / Miosite Ossificante Idioma: En Ano de publicação: 2016 Tipo de documento: Article